Search - tctmd.com

Displaying 161 - 180 of 350

Sort: Relevancy | Date

Presentation JIM 2020

Long-term antithrombotic therapy in high-risk PCI patients

Presenter: Alberto Menozzi

February 13, 2020

Presentation JIM 2020

Clinical Crossroads On Optimal Antithrombotic Therapy In Patients Treated With Pci Intravenous Antiplatelet Therapy In High Risk Acs

Presenter: Dominick Angiolillo

February 13, 2020

Presentation

Identification of Patients at Higher Risk for Myocardial Injury Following Elective PCI

October 29, 2019

Presentation TCT 2019

Case #3: Recurrent In-stent Restenosis

Presenter: Jeffrey Moses

September 28, 2019

Presentation TCT 2019

Case #2: STEMI PCI In A Newly Diabetic Patient

Presenter: Shamir Mehta

September 28, 2019

Presentation TCT 2019

Case #1: Complex PCI

Presenter: David Wohns, MD

September 28, 2019

Presentation TCT 2019

High-Risk PCI Case Review

Presenter: Kathleen Kearney

September 27, 2019

Presentation TCT 2019

Minority Women Undergoing PCI: Optimizing Outcomes in the New High-Risk PCI Cohort

Presenter: Kelly Epps

September 27, 2019

Presentation TCT 2019

Impella-Assisted PCI: Can This Strategy Prevent AKI in High-Risk Patients?

Presenter: Michael Flaherty

September 27, 2019

Presentation TCT 2019

Case Review: Complex PCI Post-TAVR Implant

Presenter: Anand Prasad

September 27, 2019

Presentation TCT 2019

PROTECT III First Look: High-Risk PCI Outcomes in 800 Impella-Supported Patients

Presenter: Jeffrey Popma

September 27, 2019

Presentation TCT 2019

Elective High-Risk PCI and Hemodynamic Support: Evidence-Based and Experience-Based Recommendations

Presenter: Divaka Perera

September 27, 2019

Presentation TCT 2019

PCI vs. CABG in Multivessel Disease (With and Without Diabetes): Latest Clinical Trial Data

Presenter: Sripal Bangalore

September 27, 2019

Presentation TCT 2019

Double Indication for Impella CP: High-Risk Percutaneous Coronary Intervention (PCI) and Acute Myocardial Infarction Complicated by Cardiogenic Shock (AMICS)

Presenter: Rafael Ferreira

September 27, 2019

Presentation TCT 2019

TWILIGHT Thrombogenicity Substudy: Impact of Ticagrelor Alone vs. Ticagrelor Plus Aspirin on Ex-Vivo Blood Thrombogenicity in High-Risk Patients Undergoing PCI

Presenter: Usman Baber

September 26, 2019

Presentation TCT 2019

TWILIGHT: A Randomized Trial of Ticagrelor Monotherapy vs. Ticagrelor-Plus-Aspirin Beginning at 3 Months in High-Risk Patients Undergoing PCI

Presenter: Roxana Mehran

September 26, 2019

Presentation TCT 2019

Case Resolution: How Did I Treat This Case?

Presenter: Pengcheng He

September 26, 2019

Presentation TCT 2019

How Would I Treat?

Presenter: Qi Zhang

September 26, 2019

Presentation TCT 2019

How Would I Treat?

Presenter: YONG HE

September 26, 2019

Presentation TCT 2019

How Would I Treat?

Presenter: Jun Pu

September 26, 2019

Advertisement

Long-term antithrombotic therapy in high-risk PCI patients

Clinical Crossroads On Optimal Antithrombotic Therapy In Patients Treated With Pci Intravenous Antiplatelet Therapy In High Risk Acs

Identification of Patients at Higher Risk for Myocardial Injury Following Elective PCI

Case #3: Recurrent In-stent Restenosis

Case #2: STEMI PCI In A Newly Diabetic Patient

Case #1: Complex PCI

High-Risk PCI Case Review

Minority Women Undergoing PCI: Optimizing Outcomes in the New High-Risk PCI Cohort

Impella-Assisted PCI: Can This Strategy Prevent AKI in High-Risk Patients?

Case Review: Complex PCI Post-TAVR Implant

PROTECT III First Look: High-Risk PCI Outcomes in 800 Impella-Supported Patients

Elective High-Risk PCI and Hemodynamic Support: Evidence-Based and Experience-Based Recommendations

PCI vs. CABG in Multivessel Disease (With and Without Diabetes): Latest Clinical Trial Data

Double Indication for Impella CP: High-Risk Percutaneous Coronary Intervention (PCI) and Acute Myocardial Infarction Complicated by Cardiogenic Shock (AMICS)

TWILIGHT Thrombogenicity Substudy: Impact of Ticagrelor Alone vs. Ticagrelor Plus Aspirin on Ex-Vivo Blood Thrombogenicity in High-Risk Patients Undergoing PCI

TWILIGHT: A Randomized Trial of Ticagrelor Monotherapy vs. Ticagrelor-Plus-Aspirin Beginning at 3 Months in High-Risk Patients Undergoing PCI

Case Resolution: How Did I Treat This Case?

How Would I Treat?

How Would I Treat?

How Would I Treat?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content